

IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids.
RELEASE NEW IMAC 2018 PROFESSIONAL
It has partnered with several active and former professional athletes, opening two Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, and a Tony Delk IMAC Regeneration Center. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000.

We expect continued growth in 2019, including increases in same-store visits and procedures, with support from operating efficiencies, increased marketing and brand awareness, and the initial results from our initiative with self-insured payors,” Jeff Ervin, IMAC’s chief executive officer added. Our near-term plans call for entering the Chicago market as we build out our anchor and satellite clinic model in this region utilizing football great Mike Ditka as a brand ambassador. “IMAC now has 11 clinics in three states, with four of them added as recently as August 2018. We look forward to utilizing the capital raised in the IPO to accelerate growth and fund expansion plans,” commented Anthony Bond, Chief Financial Officer. “IMAC’s gains in patient visits and procedures in Q4 of 2018 compared to Q4 of 2017 were reflective of growth in all areas of our business (same store clinics, development and acquisitions).
RELEASE NEW IMAC 2018 PRO
IMAC is making available actual and pro forma procedure volume and patient visit data prior to this filing as a courtesy to our shareholders and investors, who have found this operating data to be meaningful.
RELEASE NEW IMAC 2018 FULL
The company, which completed its initial public offering of common stock in February 2019, plans to report financial results for the 2018 fourth quarter and full year and file its Form 10-K for the year ended Decemwith the Securities and Exchange Commission in mid-April. Pro Forma clinics experienced a 16.2% growth in visits from 2017 compared to 2018. IMAC Holdings experienced a 1,469.8% growth in visits during 2018 compared to 2017. Pro forma clinics experienced a 21.8% growth in visits from Q4 of 2017, compared to Q4 of 2018. IMAC Holdings experienced a 1,420.6% growth in visits during Q4 of 2018 compared to Q4 of 2017. Pro Forma procedure and visit counts reflect the completion of our transactions consummated through Decemas if they had occurred on January 1, 2017. Actual procedure and visit counts are inclusive of actual patient visits and procedures for all clinics owned or managed by IMAC Holdings during the period. (Nasdaq: IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces patient visits and procedure volume at its IMAC clinics during the 2018 fourth quarter (Q4) and full year.Īll figures listed below for all periods are noted as either actual or pro forma.

BRENTWOOD, Tenn., Ma(GLOBE NEWSWIRE) - IMAC Holdings, Inc.
